Breath carbon monoxide as an indication of smoking habit

被引:311
作者
Middleton, ET
Morice, AH
机构
[1] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England
关键词
carbon monoxide; equipment and supplies; monitoring outpatients; smoking;
D O I
10.1378/chest.117.3.758
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: To assess whether the breath carbon monoxide (CO) concentration can be used to determine a patient's smoking habits in a respiratory outpatient clinic. Design: To provide a normal range for smokers and nonsmokers, 41 outpatients and 24 Healthy subjects were questioned on their smoking habits and asked to provide two breaths into a CO monitor (EC50 Smokerlyser; Bedfont Instruments; Kent, UK), In a subsequent single-blind study, 51 different outpatients were not told of the purpose of the study and were assessed by extensive questionnaire, spirometry, and Smokerlyser estimation. Setting: The Chest Clinic and Pulmonary Medicine Department at the Northern General Hospital, Sheffield, UK. Participants: Phase 1 involved 41 outpatients attending the Chest Clinic and 24 nonoutpatient colleagues, In phase 2, an additional 51 different outpatients: were studied. Measurements and results: The mean (SD) breath CO levels were 17.4 (11.6) parts per million (ppm) for smokers and 1.8 (1.3) ppm for nonsmokers (p < 0.001). A level of 6 ppm was taken as the cutoff, as this gave a selectivity of 96% and a sensitivity of 94% for outpatients. Of the 51 study patients, 5 admitted to smoking in the administered questionnaire. Eight denied smoking but had a mean breath CO > 6 ppm (7.5 to 42 ppm). Of these, three admitted to smoking after being explained the implication of the reading. Conclusions: Breath CO concentration provides an easy, noninvasive, and immediate way of assessing a patient's smoking status. A reading > 6 ppm strongly suggests that an outpatient is a smoker.
引用
收藏
页码:758 / 763
页数:6
相关论文
共 18 条
[1]   ENDOGENOUS CARBON MONOXIDE PRODUCTION [J].
COBURN, RF .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (04) :207-&
[2]   CARBON-MONOXIDE ASSESSMENT OF SMOKING IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
CROWLEY, TJ ;
ANDREWS, AE ;
CHENEY, J ;
ZERBE, G ;
PETTY, TL .
ADDICTIVE BEHAVIORS, 1989, 14 (05) :493-502
[3]  
Daly RJ, 1996, BRIT J BIOMED SCI, V53, P204
[4]  
DELLER A, 1992, INFUSIONSTHERAPIE, V19, P121
[5]   Increased levels of exhaled carbon monoxide in bronchiectasis: A new marker of oxidative stress [J].
Horvath, I ;
Loukides, S ;
Wodehouse, T ;
Kharitonov, SA ;
Cole, PJ ;
Barnes, PJ .
THORAX, 1998, 53 (10) :867-870
[6]  
HOVARTH I, 1998, EUR RESPIR J, V12, P347
[7]   CONTROLLED TRIAL OF 3 DIFFERENT ANTISMOKING INTERVENTIONS IN GENERAL-PRACTICE [J].
JAMROZIK, K ;
VESSEY, M ;
FOWLER, G ;
WALD, N ;
PARKER, G ;
VANVUNAKIS, H .
BRITISH MEDICAL JOURNAL, 1984, 288 (6429) :1499-1503
[8]  
JARVIS M, 1984, J EPIDEMIOL COMMUN H, V38, P335, DOI 10.1136/jech.38.4.335
[9]   COMPARISON OF TESTS USED TO DISTINGUISH SMOKERS FROM NONSMOKERS [J].
JARVIS, MJ ;
TUNSTALLPEDOE, H ;
FEYERABEND, C ;
VESEY, C ;
SALOOJEE, Y .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (11) :1435-1438
[10]   LOW-COST CARBON-MONOXIDE MONITORS IN SMOKING ASSESSMENT [J].
JARVIS, MJ ;
BELCHER, M ;
VESEY, C ;
HUTCHISON, DCS .
THORAX, 1986, 41 (11) :886-887